Suppr超能文献

头孢雷特在血液透析中的药代动力学:超滤的影响。

Ceforanide pharmacokinetics in haemodialysis: the effect of ultrafiltration.

作者信息

Lanao J M, de Prada C R, Dominguez-Gil A, Tabernero J M, Martín J, Gómez J R

出版信息

Biopharm Drug Dispos. 1986 Jul-Aug;7(4):335-46. doi: 10.1002/bdd.2510070404.

Abstract

The kinetics of ceforanide in plasma and dialysate was studied in 8 patients with terminal renal impairment after undergoing haemodialysis sessions lasting between 4 and 5 h. All patients received a single i.v. dose of 15 mg kg-1 of the drug at the start of the session. The dialysers used in this study were Spiraflow capillar 1.3 m2, Travenol plates 1.4 m2, and PAN plates. Blood flow ranged between 200 and 300 ml min-1 and dialysate flow between 500-650 ml min-1. Plasma ceforanide levels were measured at the input and output of the dialyser and the antibiotic levels in dialysate were determined coinciding with the withdrawal times of the blood samples. A microbiologic plate diffusion method was used to determine the antibiotic concentrations. The mean values of some pharmacokinetic parameters of ceforanide calculated with a non-linear regression program from the data obtained from arterial blood were the following: alpha (h-1) = 4.14 +/- 1.32; beta (h-1) = 0.26 +/- 0.07; t1/2 beta (h) = 2.82 +/- 0.82; Vdss (1) = 10.24 +/- 2.14. From the relationships between the antibiotic concentrations at the input and output of the dialyser it was possible to calculate an extraction coefficient of 0.11 +/- 0.06. The dialysis clearance of ceforanide was calculated from the determination of the extraction coefficient and from the measuring of antibiotic in dialysate, though different results were obtained with the two methods. Dialysis clearance calculated from the extraction coefficient showed a mean value of 18.68 +/- 12.16 ml min-1, significantly lower (p less than 0.01) than that established by analysis of the antibiotic in dialysate, which was 41.55 +/- 15.83 ml min-1. These differences may be attributed to problems related to the determination of blood flow and to the ultrafiltration capacity of the dialysis membranes. A linear relationship was established between the percentage error in the observed and predicted extraction coefficients and the ultrafiltration rate. The results obtained suggest that the simultaneous measurement of the antibiotic in plasma and dialysate is the most suitable method for predicting the dialysis clearance of the drug. The amount of antibiotic extracted over a 4-hour dialysis session proved to be equal to 57.85 +/- 15.62 per cent of the dose administered.

摘要

对8例终末期肾功能损害患者在进行4至5小时的血液透析后,研究了头孢乙腈在血浆和透析液中的动力学。所有患者在透析开始时静脉注射单剂量15mg/kg的该药物。本研究中使用的透析器有Spiraflow毛细管1.3平方米、Travenol平板1.4平方米和聚砜平板。血流量在200至300ml/min之间,透析液流量在500 - 650ml/min之间。在透析器的输入端和输出端测量血浆头孢乙腈水平,并在采集血样的同时测定透析液中的抗生素水平。采用微生物平板扩散法测定抗生素浓度。根据从动脉血获得的数据,用非线性回归程序计算出的头孢乙腈的一些药代动力学参数的平均值如下:α(h⁻¹)= 4.14±1.32;β(h⁻¹)= 0.26±0.07;t₁/₂β(h)= 2.82±0.82;Vdss(L)= 10.24±2.14。根据透析器输入端和输出端抗生素浓度之间的关系,可以计算出提取系数为0.11±0.06。头孢乙腈的透析清除率是根据提取系数的测定和透析液中抗生素的测量来计算的,不过两种方法得到了不同的结果。根据提取系数计算出的透析清除率平均值为18.68±12.16ml/min,显著低于(p<0.01)通过分析透析液中的抗生素确定的清除率,后者为41.55±15.83ml/min。这些差异可能归因于与血流量测定和透析膜超滤能力相关的问题。在观察到的和预测的提取系数的百分比误差与超滤率之间建立了线性关系。所得结果表明,同时测量血浆和透析液中的抗生素是预测该药物透析清除率的最合适方法。在4小时的透析过程中提取的抗生素量被证明等于给药剂量的57.8%±1:5.62%。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验